Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Astrocytoma × fluoromisonidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Sarcoma 2 Glioma 2 Brain Neoplasms 2 Small Cell Lung Carcinoma 1 Neoplasms 1 Meningioma 1 Lung Neoplasms 1 Carcinoma, Hepatocellular 1 Astrocytoma 1

Interventions

Temozolomide 17 Radiotherapy 5 Bevacizumab 5 Filgrastim 4 vocimagene amiretrorepvec 3 sargramostim 3 etoposide phosphate 3 antineoplaston AS 2-1 3 antineoplaston A10 3 O(6)-benzylguanine 3 Melphalan 3 Flucytosine 3 Dynamic Contrast Enhanced Magnetic Resonance Imaging 3 Carmustine 3 Aminolevulinic Acid 3 tovorafenib 2 palbociclib 2 cabozantinib 2 Topotecan 2 Thiotepa 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Perfusion Magnetic Resonance Imaging 2 Lomustine 2 Irinotecan 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Gadolinium DTPA 2 Etoposide 2 Erlotinib Hydrochloride 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01868906 2018-08-24

FMISOPETSCS

Dr. Negrin University Hospital

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡